RALPH ORLAND: Open Payments
NPI 1265496681 · WHEATON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,268 in 59 payments from 16 companies in 2025. Trend: 2023 $1,006 · 2024 $1,071 · 2025 $1,268
Food & beverage: $1,268
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $172 |
| Neurocrine BioSciences, Inc. | 5 | $133 |
| Axsome Therapeutics, Inc. | 6 | $129 |
| Vanda Pharmaceuticals Inc. | 4 | $109 |
| ABBVIE INC. | 5 | $104 |
| Alkermes, Inc. | 4 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $92 |
| Collegium Pharmaceutical, Inc. | 3 | $71 |
| Lundbeck LLC | 3 | $63 |
| Tris Pharma Inc | 3 | $54 |
Products named: REXULTI, INGREZZA, FANAPT, VRAYLAR, ARISTADA, CAPLYTA, Sunosi, Jornay PM.
Industry payments across IL — which companies pay providers there.
